E-LIB Suche - Ergebnisse für: Ridder, Bradley J.

1

A systematic strategy for estimating hERG block potency and..:

Ridder, Bradley J. ; Leishman, Derek J. ; Bridgland-Taylor, Matthew...
Toxicology and Applied Pharmacology. 394 (2020) - p. 114961 , 2020

Link: https://doi.org/10.1016/..

2

Corrigendum to "A systematic strategy for estimating hERG b..:

Ridder, Bradley J. ; Leishman, Derek J. ; Bridgland-Taylor, Matthew...
Toxicology and Applied Pharmacology. 395 (2020) - p. 114983 , 2020

Link: https://doi.org/10.1016/..

3

A general procedure to select calibration drugs for lab-spe..:

Han, Xiaomei ; Samieegohar, Mohammadreza ; Ridder, Bradley J....
Journal of Pharmacological and Toxicological Methods. 105 (2020) - p. 106890 , 2020

Link: https://doi.org/10.1016/..

4

General Principles for the Validation of Proarrhythmia Risk..:

Li, Zhihua ; Mirams, Gary R. ; Yoshinaga, Takashi...
Clinical Pharmacology & Therapeutics. 107 (2019) 1 - p. 102-111 , 2019

Link: https://doi.org/10.1002/..

5

Assessment of an In Silico Mechanistic Model for Proarrhyth..:

Li, Zhihua ; Ridder, Bradley J. ; Han, Xiaomei...
Clinical Pharmacology & Therapeutics. 105 (2018) 2 - p. 466-475 , 2018

Link: https://doi.org/10.1002/..

6

Parametric, Optimization-Based Study on the Feasibility of ..:

Ridder, Bradley J. ; Majumder, Aniruddha ; Nagy, Zoltan K.
Industrial & Engineering Chemistry Research. 55 (2016) 8 - p. 2371-2380 , 2016

Link: https://doi.org/10.1021/..

7

Population Balance Model-Based Multiobjective Optimization ..:

Ridder, Bradley J. ; Majumder, Aniruddha ; Nagy, Zoltan K.
Industrial & Engineering Chemistry Research. 53 (2014) 11 - p. 4387-4397 , 2014

Link: https://doi.org/10.1021/..

8

A systematic strategy for estimating hERG block potency and..:

Ridder, Bradley J ; Leishman, Derek J ; Bridgland-Taylor, Matthew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166077/. , 2020

Link: http://www.ncbi.nlm.nih...

9

Corrigendum to "A systematic strategy for estimating hERG b..:

Ridder, Bradley J ; Leishman, Derek J ; Bridgland-Taylor, Matthew...
https://nottingham-repository.worktribe.com/output/4304853. , 2020

Link: https://doi.org/10.1016/..

10

A systematic strategy for estimating hERG block potency and..:

Ridder, Bradley J ; Leishman, Derek J ; Bridgland-Taylor, Matthew...
https://nottingham-repository.worktribe.com/output/4198126. , 2020

Link: https://doi.org/10.1016/..

11

General principles for the validation of proarrhythmia risk..:

Li, Zhihua ; Mirams, Gary R ; Yoshinaga, Takashi...
http://eprints.gla.ac.uk/221023/1/221023.pdf. , 2020

Link: http://eprints.gla.ac.uk..

12

General Principles for the Validation of Proarrhythmia Risk..:

Li, Zhihua ; Mirams, Gary R ; Yoshinaga, Takashi...
qt5g79813n. , 2020

Link: https://escholarship.org..

13

General Principles for the Validation of Proarrhythmia Risk..:

Li, Zhihua ; Mirams, Gary R ; Yoshinaga, Takashi...
https://nottingham-repository.worktribe.com/output/3206765. , 2019

Link: https://doi.org/10.1002/..

14

General principles for the validation of proarrhythmia risk..:

Li, Zhihua ; Mirams, Gary ; Yoshinaga, Takashi...
CLINICAL PHARMACOLOGY AND THERAPEUTICS. , 2019

Link: https://trepo.tuni.fi/ha..

15

General Principles for the Validation of Proarrhythmia Risk..:

Li, Zhihua ; Mirams, Gary R ; Yoshinaga, Takashi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977398/. , 2019

Link: http://www.ncbi.nlm.nih...